IMPROVED HILIC LC/MS ANALYSIS OF HEPARINOIDS USING A MAKEUP FLOW CHIP

使用补充流芯片改进类肝素的 HILIC LC/MS 分析

基本信息

  • 批准号:
    7955954
  • 负责人:
  • 金额:
    $ 1.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-01 至 2010-05-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Heparin and heparan sulfate (HS) are glycosaminoglycans (GAGs) comprised of alternating glucuronic acid and N-acetylglucosamine units. These molecules are most widely recognized for their ability to bind proteins and modulate cellular events such as differentiation, blood coagulation, pathogenesis, and proliferation. Full understanding of these events requires knowledge of GAG structure. Although chip-based hydrophilic interaction chromatography (HILIC) is a powerful means of separating GAGs for on-line LC/MS, the negative-ion spray becomes unstable in high percent aqueous mobile phases. This work demonstrates the effectiveness of a chip designed with post-column addition of makeup LC flow to enable stable electrospray throughout the HILIC gradient. The result is a system with substantially increased spray stability and range of analytes that may be effectively analyzed. Porcine intestinal mucosa derived heparin was partially digested (30% reaction completion) with heparin lyase I. The resultant oligosaccharides were separated on a 1.75-meter size exclusion chromatography (SEC) column and pooled based on degree of polymerization. Bovine kidney HS was partially digested (10 or 20% reaction completion) to oligosaccharides with a mixture of heparin lyases I, II, and III. HS oligosaccharides as well as the low molecular weight heparin drugs Fragmin and Lovenox were purified by SEC-HPLC using a Superdex Peptide column. Samples were injected onto a custom-packed amide make-up flow HPLC-chip that was interfaced with an Agilent 6520 QTOF. Glycan compositions were assigned using a Microsoft Excel database and abundances calculated based on integrated peak area in the MS mode.
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 肝素和硫酸肝素(HS)是由交替的葡萄糖糖醛酸和N-乙酰氨基葡萄糖单元组成的糖胺多聚糖(GAG)。这些分子最广为人知的是它们能够结合蛋白质并调节细胞事件,如分化、凝血、发病和增殖。对这些事件的充分理解需要对GAG结构的了解。尽管芯片亲水作用色谱柱(HILIC)是一种强有力的在线LC/MS分离手段,但负离子喷雾在高含量水相流动相中变得不稳定。这项工作证明了一种芯片的有效性,该芯片采用柱后添加的补充液相流设计,能够在整个HILIC梯度中实现稳定的电喷雾。其结果是系统的喷雾稳定性和可有效分析的分析物范围显著增加。 用肝素裂解酶I对猪肠黏膜肝素进行部分消化(反应完成率为30%),得到的低聚糖在1.75m的尺寸排除色谱柱(SEC)上分离,并按聚合度合并。用肝素裂解酶I、II和III的混合物将牛肾HS部分消化(反应完成率为10%或20%)为寡糖。HS寡糖以及低分子肝素药物Fragmin和Lovenox用Superdex多肽柱通过SEC-HPLC纯化。样品被注入到定制包装的酰胺化妆流动高效液相芯片上,该芯片与Agilent 6520 QTOF接口。使用Microsoft Excel数据库指定多糖组成,并在MS模式下基于积分峰面积计算丰度。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEPH ZAIA其他文献

JOSEPH ZAIA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEPH ZAIA', 18)}}的其他基金

Methods for measuring matrisome molecule similarity during disease processes
测量疾病过程中基质体分子相似性的方法
  • 批准号:
    10582128
  • 财政年份:
    2022
  • 资助金额:
    $ 1.89万
  • 项目类别:
Methods for measuring matrisome molecule similarity during disease processes
测量疾病过程中基质体分子相似性的方法
  • 批准号:
    10580774
  • 财政年份:
    2022
  • 资助金额:
    $ 1.89万
  • 项目类别:
Methods for measuring matrisome molecule similarity during disease processes
测量疾病过程中基质体分子相似性的方法
  • 批准号:
    10330789
  • 财政年份:
    2022
  • 资助金额:
    $ 1.89万
  • 项目类别:
Methods for determination of glycoprotein glycosylation similarities among disease states
确定疾病状态之间糖蛋白糖基化相似性的方法
  • 批准号:
    10194553
  • 财政年份:
    2019
  • 资助金额:
    $ 1.89万
  • 项目类别:
An open-source software suite for processing glycomics and glycoproteomics mass spectral data
用于处理糖组学和糖蛋白质组学质谱数据的开源软件套件
  • 批准号:
    9391486
  • 财政年份:
    2017
  • 资助金额:
    $ 1.89万
  • 项目类别:
A Thermo-Fisher Scientific Q-Exactive HF Mass Spectrometry System
Thermo-Fisher Scientific Q-Exactive HF 质谱系统
  • 批准号:
    9075665
  • 财政年份:
    2016
  • 资助金额:
    $ 1.89万
  • 项目类别:
Software for automated interpretation of heparan sulfate tandem mass spectra
用于自动解释硫酸乙酰肝素串联质谱的软件
  • 批准号:
    9337106
  • 财政年份:
    2015
  • 资助金额:
    $ 1.89万
  • 项目类别:
Software for automated interpretation of heparan sulfate tandem mass spectra
用于自动解释硫酸乙酰肝素串联质谱的软件
  • 批准号:
    9144851
  • 财政年份:
    2015
  • 资助金额:
    $ 1.89万
  • 项目类别:
Software for automated interpretation of heparan sulfate tandem mass spectra
用于自动解释硫酸乙酰肝素串联质谱的软件
  • 批准号:
    8984998
  • 财政年份:
    2015
  • 资助金额:
    $ 1.89万
  • 项目类别:
Quantitative profiling of glycosaminoglycans from breast tumor tissue arrays
乳腺肿瘤组织阵列中糖胺聚糖的定量分析
  • 批准号:
    9079438
  • 财政年份:
    2014
  • 资助金额:
    $ 1.89万
  • 项目类别:

相似海外基金

Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
  • 批准号:
    2140205
  • 财政年份:
    2022
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Standard Grant
Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
  • 批准号:
    2140196
  • 财政年份:
    2022
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Standard Grant
Atroposelective Synthesis of Hindered Amides - Exploration of Synthetic Peptide Catalysts -
受阻酰胺的天体选择性合成-合成肽催化剂的探索-
  • 批准号:
    504378162
  • 财政年份:
    2022
  • 资助金额:
    $ 1.89万
  • 项目类别:
    WBP Fellowship
Development of Peptide Chemical Modification Enabled by N-Halogenation of Amides
酰胺 N-卤化实现的肽化学修饰的发展
  • 批准号:
    22H02743
  • 财政年份:
    2022
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
  • 批准号:
    10532252
  • 财政年份:
    2021
  • 资助金额:
    $ 1.89万
  • 项目类别:
CAREER: SusChEM: Iron Catalysts for the Reduction of Amides
职业:SusChEM:用于还原酰胺的铁催化剂
  • 批准号:
    2146728
  • 财政年份:
    2021
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Continuing Grant
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
  • 批准号:
    10399712
  • 财政年份:
    2021
  • 资助金额:
    $ 1.89万
  • 项目类别:
Function of primary fatty acid amides as lipid mediators
伯脂肪酸酰胺作为脂质介质的功能
  • 批准号:
    20K21285
  • 财政年份:
    2020
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Nickel-Catalyzed Alpha-Arylation of Secondary Amides
镍催化仲酰胺的α-芳基化
  • 批准号:
    558383-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Canadian Graduate Scholarships Foreign Study Supplements
Catalytic Synthesis of Pharmaceutical Amides in Water
水中催化合成药用酰胺
  • 批准号:
    EP/T01430X/1
  • 财政年份:
    2020
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了